EUVIMEDEUVIMED entdecken
Crossref

L26/P-517 Serum progesterone and estradiol levels on the first pregnancy test day as predictors of live birth after fresh embryo transfer

T. Aouragh, C. Roelens, N. Ranisavljevic, L. Van Landuyt, M. De Vos, H. Tournaye, C. Blockeel, S. Mackens

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Aouragh und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do serum progesterone and estradiol levels on the first pregnancy test day have predictive value for live birth (LB) after fresh embryo transfer (fresh ET)? Summary answer Serum progesterone and estradiol on pregnancy test day predicted live birth probability, a multivariable model estimated individualized live birth probability. What is known already In fresh embryo transfer cycles, ovarian stimulation induces supraphysiological estradiol levels, suppressing luteinizing hormone secretion and resulting in luteal phase insufficiency requiring luteal phase support. Studies evaluating serum progesterone have demonstrated that both insufficient and excessive concentrations are associated with reduced pregnancy rates, suggesting the existence of an optimal therapeutic window (60–100 nmol/L in the early luteal phase and 150–250 nmol/L in the mid-luteal phase). In contrast, ideal estradiol levels during the luteal phase have not been clearly established and hormonal profiles later in the luteal phase, particularly at the time of pregnancy testing, also remain poorly defined. Study design, size, duration A retrospective single-center cohort study analyzed 771 fresh embryo transfer cycles performed at a tertiary, university-affiliated IVF center between November 2020 and March 2024. Serum progesterone and estradiol were measured in-house on the scheduled pregnancy test day, 9-12 days after fresh ET. The primary objective was to identify clinically relevant hormonal thresholds and to develop a multivariable model enabling individualized estimation of live birth probability based on hormone levels measured on the pregnancy test day. Participants/materials, setting, methods All patients undergoing fresh blastocyst transfer with a positive serum hCG (>10 IU/L) during the study period and a BMI <35 kg/m² were retrospectively analyzed. Each patient was included only once. Luteal phase support was initiated the day after oocyte retrieval, mainly using vaginal progesterone only (93.4%). Exclusion criteria included recurrent pregnancy loss (≥2 losses <10 weeks), uterine pathology, embryos derived from in vitro maturation, oocyte donation, and cleavage-stage embryo transfer. Main results and the role of chance In the analyzed cohort of 771 fresh embryo transfer cycles, mean maternal age was 34.10 ± 4.34 years and mean BMI was 24.35 ± 4.52 kg/m². Mean serum progesterone and estradiol concentrations on the pregnancy test day were 44.66 ± 19.60 µg/L and 806.51 ± 712.41 ng/L, respectively. In multivariable logistic regression, higher progesterone (OR 1.054 per µg/L, 95% CI 1.040–1.068; p < 0.001) and estradiol (OR 1.003 per ng/L, 95% CI 1.001–1.005; p = 0.009) were associated with increased odds of live birth. A significant progesterone-estradiol interaction (p = 0.006) indicated interdependent hormonal effects. Consistently, binned analyses demonstrated progressively higher live birth rates with increasing progesterone and estradiol concentrations, followed by a plateau around 25 µg/L for progesterone and approximately 700 ng/L for estradiol. Maternal age was inversely associated with live birth (OR 0.911 per year, 95% CI 0.873–0.950; p < 0.001), while cycles with a male-factor indication showed higher odds of live birth (OR 1.57, 95% CI 1.06–2.32; p = 0.024). The final model was statistically significant (χ²=134.59, p < 0.001), demonstrated acceptable discrimination (AUC 0.745), explained 24% of variance (Nagelkerke R² = 0.243) and correctly classified 74.8% of cycles. A probability threshold of 0.72 yielded balanced sensitivity and specificity (both 69%). Limitations, reasons for caution As a retrospective study from a single center, selection bias and residual confounding cannot be excluded. Progesterone values exceeding the assay detection limit (60 µg/L) were truncated at 61 µg/L, which may bias estimates at higher concentrations. More advanced statistical approaches will be planned to address this limitation. Wider implications of the findings In line with our findings in frozen cycles, the results suggest that progesterone and estradiol levels on the first pregnancy test day after fresh ET are important predictors of LB probability. Whether preventive strategies using additional progesterone or estradiol can counteract a low probability of LB requires further evaluation. Trial registration number No

Zitieren

APA

Aouragh, T., Roelens, C., Ranisavljevic, N., Landuyt, L. V., Vos, M. D., Tournaye, H., Blockeel, C., & Mackens, S. (2026). L26/P-517 Serum progesterone and estradiol levels on the first pregnancy test day as predictors of live birth after fresh embryo transfer. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.850

Vancouver

Aouragh T, Roelens C, Ranisavljevic N, Landuyt LV, Vos MD, Tournaye H, et al. L26/P-517 Serum progesterone and estradiol levels on the first pregnancy test day as predictors of live birth after fresh embryo transfer. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.850

BibTeX
@article{Aouragh2026,
  author = {Aouragh, T. and Roelens, C. and Ranisavljevic, N. and Landuyt, L. Van and Vos, M. De and Tournaye, H. and Blockeel, C. and Mackens, S.},
  title = {L26/P-517 Serum progesterone and estradiol levels on the first pregnancy test day as predictors of live birth after fresh embryo transfer},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.850}
}
Kostenlos starten →